<unk>  is usually detected shortly after birth, affecting 6% to 8% of all newborns in neonatal intensive care units (NICUs). Out of the approximately 600,000 neonates annually treated in NICUs in the United States, 48,000 may be diagnosed as<unk> . The incidence of<unk>  is greater in premature infants. Six to fifty-eight percent of preterm neonates are diagnosed with this auto-immune disease. The incidence of<unk>  correlates with decreasing birth weight. The disorder is seen up to 38% in infants that weigh less than 1000g, 13% in infants weighing less than 2500g, and 3% of term infants weighing more than 2500 g.<unk>  is often temporary, affecting most newborns in only first few days after birth. In others, it becomes more severe and chronic indicating a deficiency in innate immunity. Furthermore, the prevalence of chronic<unk>  in the general public is rare. In a study conducted in Denmark, over 370,000 people were assessed for the presence of<unk> . Results published demonstrated only 1% of those evaluated were<unk> , and were commonly seen in those suffering from HIV, viral infections, acute leukemias, and myelodysplastic syndromes. The study concluded the presence of<unk>  is an ominous sign that warrants further investigation and follow-up.
Neutropenia
Monocytosis
Macrocytosis
Poikilocytosis
Mastocytosis
Monocytopenia
Hypersegmented neutrophil
Dyscrasia